Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Nichola68773113 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1456208134805000199.png) Nicholas Meyer [@Nichola68773113](/creator/twitter/Nichola68773113) on x XX followers
Created: 2025-07-18 13:11:24 UTC

$nvct dual news next week!!!!
1: NXP-800 1b data. Very much expect >15% ORR (3x effective as SOC) and move to phase X (approval after 2a which is a confirmatory of 1v

2: NXP-900 start 1b for >200k patient TAM in single and combo therapy for NSCLC. Analogous to $smmt


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946196104485237027/c:line.svg)

**Related Topics**
[combo](/topic/combo)
[soc](/topic/soc)
[$nvct](/topic/$nvct)
[$smmt](/topic/$smmt)

[Post Link](https://x.com/Nichola68773113/status/1946196104485237027)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Nichola68773113 Avatar Nicholas Meyer @Nichola68773113 on x XX followers Created: 2025-07-18 13:11:24 UTC

$nvct dual news next week!!!! 1: NXP-800 1b data. Very much expect >15% ORR (3x effective as SOC) and move to phase X (approval after 2a which is a confirmatory of 1v

2: NXP-900 start 1b for >200k patient TAM in single and combo therapy for NSCLC. Analogous to $smmt

XXX engagements

Engagements Line Chart

Related Topics combo soc $nvct $smmt

Post Link

post/tweet::1946196104485237027
/post/tweet::1946196104485237027